Gregory Ainsworth

Gregory is a scientist, analytical development at Verve Therapeutics. Prior to joining Verve, Greg worked at Sarepta Therapeutics managing quality control and analytical development activities for gene therapy products. He received his M.S in chemistry, focusing on biochemistry, from the University of Massachusetts-Lowell, where he explored the role of oxidized fatty acids in modulating triglyceride levels. He received his B.S. in chemistry from Emmanuel College.